MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 225 filers reported holding MYRIAD GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,002,382 | -30.7% | 9,164,737 | +0.1% | 0.00% | -20.0% |
| Q2 2023 | $212,151,404 | -1.8% | 9,152,347 | -1.6% | 0.01% | 0.0% |
| Q1 2023 | $216,002,158 | +59.9% | 9,298,414 | -0.1% | 0.01% | +25.0% |
| Q4 2022 | $135,113,652 | -22.4% | 9,311,761 | +2.0% | 0.00% | -20.0% |
| Q3 2022 | $174,170,000 | +6.4% | 9,128,384 | +1.4% | 0.01% | 0.0% |
| Q2 2022 | $163,651,000 | -27.7% | 9,006,680 | +0.3% | 0.01% | 0.0% |
| Q1 2022 | $226,211,000 | -10.4% | 8,976,593 | -1.9% | 0.01% | -16.7% |
| Q4 2021 | $252,527,000 | -13.4% | 9,149,521 | +1.3% | 0.01% | -14.3% |
| Q3 2021 | $291,681,000 | +6.6% | 9,033,197 | +0.9% | 0.01% | 0.0% |
| Q2 2021 | $273,716,000 | +4.2% | 8,950,820 | +3.8% | 0.01% | 0.0% |
| Q1 2021 | $262,621,000 | +60.1% | 8,624,665 | +4.0% | 0.01% | +40.0% |
| Q4 2020 | $164,070,000 | +57.3% | 8,296,864 | +3.7% | 0.01% | +66.7% |
| Q3 2020 | $104,295,000 | +11.5% | 7,998,018 | -3.0% | 0.00% | 0.0% |
| Q2 2020 | $93,514,000 | -21.9% | 8,246,412 | -1.4% | 0.00% | -40.0% |
| Q1 2020 | $119,710,000 | -47.2% | 8,365,447 | +0.5% | 0.01% | -37.5% |
| Q4 2019 | $226,569,000 | -8.5% | 8,320,574 | -3.8% | 0.01% | -11.1% |
| Q3 2019 | $247,655,000 | +7.1% | 8,650,251 | +3.9% | 0.01% | 0.0% |
| Q2 2019 | $231,234,000 | -18.4% | 8,323,769 | -2.5% | 0.01% | -18.2% |
| Q1 2019 | $283,471,000 | +6.1% | 8,538,277 | -7.1% | 0.01% | -8.3% |
| Q4 2018 | $267,233,000 | -32.9% | 9,192,715 | +6.2% | 0.01% | -25.0% |
| Q3 2018 | $398,219,000 | +28.5% | 8,656,933 | +4.4% | 0.02% | +23.1% |
| Q2 2018 | $309,843,000 | +34.9% | 8,291,236 | +6.6% | 0.01% | +30.0% |
| Q1 2018 | $229,742,000 | -7.4% | 7,774,668 | +7.6% | 0.01% | -9.1% |
| Q4 2017 | $248,118,000 | +8.4% | 7,224,302 | +14.2% | 0.01% | 0.0% |
| Q3 2017 | $228,930,000 | +40.5% | 6,327,512 | +0.3% | 0.01% | +37.5% |
| Q2 2017 | $162,992,000 | +35.8% | 6,307,738 | +0.9% | 0.01% | +33.3% |
| Q1 2017 | $120,020,000 | +34.5% | 6,251,030 | +16.8% | 0.01% | +20.0% |
| Q4 2016 | $89,248,000 | -16.5% | 5,353,743 | +3.1% | 0.01% | -16.7% |
| Q3 2016 | $106,918,000 | -32.8% | 5,195,212 | -0.0% | 0.01% | -40.0% |
| Q2 2016 | $159,018,000 | -16.3% | 5,196,666 | +2.4% | 0.01% | -16.7% |
| Q1 2016 | $189,956,000 | -9.3% | 5,074,985 | +4.6% | 0.01% | -14.3% |
| Q4 2015 | $209,484,000 | +19.4% | 4,853,649 | +3.7% | 0.01% | +100.0% |
| Q3 2015 | $175,415,000 | +10.1% | 4,680,243 | -0.2% | 0.01% | -36.4% |
| Q2 2015 | $159,335,000 | -5.2% | 4,687,675 | -1.3% | 0.01% | 0.0% |
| Q1 2015 | $168,080,000 | +3.8% | 4,748,029 | -0.1% | 0.01% | -8.3% |
| Q4 2014 | $161,875,000 | -12.5% | 4,752,636 | -1.0% | 0.01% | -14.3% |
| Q3 2014 | $185,077,000 | -5.8% | 4,798,467 | -5.0% | 0.01% | -6.7% |
| Q2 2014 | $196,572,000 | +18.0% | 5,050,663 | +3.7% | 0.02% | +7.1% |
| Q1 2014 | $166,526,000 | +62.5% | 4,870,590 | -0.3% | 0.01% | +55.6% |
| Q4 2013 | $102,495,000 | -9.9% | 4,885,391 | +0.9% | 0.01% | -18.2% |
| Q3 2013 | $113,740,000 | -3.8% | 4,839,989 | +10.0% | 0.01% | -8.3% |
| Q2 2013 | $118,230,000 | – | 4,400,097 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |